Q3 2026: up everywhere, for the same reason
The ketoconazole price index rose quarter-over-quarter in all three regions ChemAnalyst tracks. Production costs drove the rise more than demand did.
- USA: The index has now risen for four straight quarters, from Q4 2025 to Q3 2026.
- China: The index has risen for three straight quarters after a dip in Q4 2025.
- Germany: The index rose again after holding stable in Q2 2026.
Prices hovered around USD 72,000/MT FOB India in Q3 2026, the same level assessed in Q2.
The squeeze: costs rising faster than shelf prices
The macro figures ChemAnalyst cites show the same pattern in all three markets. Input prices are rising faster than consumer prices, so API makers absorb the cost before they can pass it on.
- USA: Producer prices rose 6.3% year-over-year in September, against consumer price inflation of 3.7%. That’s a gap of about 2.6 points*.
- China: Producer prices rose 5.0% in September, against consumer price inflation of 0.9%. That’s a gap of about 4.1 points*, the widest of the three.
- Germany: Intermediate goods producer prices rose 4.6% in August, against consumer price inflation of 3.3% in September. That’s a gap of about 1.3 points*.
USA: costs and OTC demand both push up
In the US, the index rose on higher producer input costs. Stronger global oil prices in 2026 raised energy and feedstock costs. Unlike the other two regions, demand also helped: retail sales grew 6.3% year-over-year in September, which supported over-the-counter antifungal products. A growing US pharmaceutical market and low unemployment (4.2%) kept healthcare spending steady.
China: cost-led, but with little pricing power
In China, high factory-gate inflation raised precursor and intermediate costs, which pushed the index up. Demand was weaker. Retail sales grew only 1.1% in Q3, which held back growth in retail-grade antifungal products. Mild consumer inflation also limited how much formulators could pass on higher upstream costs. The expanding manufacturing index and 5.3% growth in industrial production kept fine chemical supply chains running and batch capacity reliable. Spot prices reflected balanced regional output after scheduled plant maintenance.
Germany: energy-driven costs, soft demand
In Germany, wholesale electricity prices rose sharply in September, and intermediate goods prices increased, both raising production costs. Demand was weak. Retail sales fell 0.4% in August, consumer confidence was at -14.5 in September, and the manufacturing index was contracting. Customers built inventories in September, which eased supply for chemical companies.
How the trend built
- Q4 2025: China and Germany fell as producer prices declined, while the US rose on higher natural gas costs.
- Q1 2026: All three regions rose on feedstock shocks. Benzene and propylene tightened in the US, imidazole costs rose in China, and energy costs jumped in Germany.
- Q2 2026: The US and China kept rising. Germany held stable.
- Q3 2026: All three rose again.
What to watch
Costs are still pushing prices up, but demand is uneven. US OTC demand is strong, while consumer demand in China and Germany is soft. German customers’ restocking in September has already eased supply. Whether producers can keep passing on costs will depend on whether end-market demand catches up with input inflation.
Track ketoconazole with ChemAnalyst
ChemAnalyst tracks weekly prices for 1,000+ commodities, explains why prices moved, and publishes forecasts. Its analysts monitor plant shutdowns and 50+ ports from offices in Houston, Cologne and New Delhi.
Book a free demo: https://www.chemanalyst.com/ChemAnalyst/PricingForm?Product=Ketoconazole
Comments